• Main Menu
Annual Scientific Meeting GSA Enrich GSA Connect KAER Reframing Aging
Login
Join Donate
GSA 2025 Event
  • Home
  • Registration
  • Submissions
    • Call for Late Breaking Abstracts
    • GSA 2025 Speakers
  • Travel
  • Program
  • Exhibits & Sponsorship
  • Experience Boston
GSA 2025 EventGSA 2025 Event
  • Home
  • Registration
  • Submissions
    • Call for Late Breaking Abstracts
    • GSA 2025 Speakers
  • Travel
  • Program
  • Exhibits & Sponsorship
  • Experience Boston

Momentum Discussions

Home
  • Program
  • GSA 2025 Momentum Discussions

Momentum Discussions

Covering a broad range of aging topics, these discussions highlight the latest research and innovative solutions. Audience participation is encouraged to explore ways to improve the lives of older adults.

Sign up and Participate

Momentum Discussions will be held on Thursday and Friday of the conference from 3:00 PM - 4:00 PM. These sessions are included with your conference registration, but space is limited-sign up to secure your spot today! 

Register Now

Thursday, November 13

Time: 3:00 PM - 4:00 PM
Location: Hynes Convention Center

Anti-amyloid monoclonal antibody (mAb) therapies for early symptomatic Alzheimer’s disease, including mild cognitive impairment and mild dementia. These treatments aim to slow or halt the progression of Alzheimer's disease by addressing the underlying causes rather than just managing symptoms. Data support that individuals receiving these therapies experience slower disease progression resulting in the potential to extend their independence in activities of daily living and instrumental activities of daily living. This Momentum Discussion brings the clinical outcomes associated with mAb therapies through reflections of patients receiving the treatments and those who support them.


Sponsored by Eisai.

Increased life expectancy is reshaping health care and workforce dynamics, highlighting the impact of chronic health conditions and the shortage of health care professionals. This session will explore actionable strategies to prepare for the challenges and opportunities of an aging population.


Sponsored by TIAA Institute.



The chronic disease of obesity, combined with age-related changes and other health conditions, results in complexities when managing obesity in women as they age. Interprofessional care teams need a comprehensive, personalized approach, including lifestyle interventions and the availability of a full range of treatment options. This session will highlight trends in the care of women with obesity as they age.


Sponsored by Novo Nordisk and Haleon.

Despite their health, economic, and societal benefits, vaccine acceptance in the current climate is uncertain. This session will address why older adult vaccination should continue to be a priority to prevent certain illnesses. A multidisciplinary panel will explore the current state of the vaccine landscape.


Sponsored by GSK, Johnson & Johnson, Pfizer, CSL Seqirus, and Sanofi.

Friday, November 14

Time: 3:00 PM – 4:00 PM
Location: Hynes Convention Center

There is a lack of awareness of older adults’ opioid use and misuse across the United States, including health care professionals. This session explores realities in opioid use and exposure among this diverse population and introduces a new GSA resource aimed at improving older adult safety.


Sponsored by Emergent BioSolutions.

This group of retired physicians living with dementia will provide an insightful session sharing their personal journeys. Despite their medical knowledge, they faced significant hurdles in securing a diagnosis and support. In this session, they will walk you through their experiences, aiming to reshape perceptions and promote compassionate care. Motivated to improve experiences for others, they created a practical symptom checklist for patients, families, service providers, and physicians. They will share this as well as essential information and resources needed for those newly diagnosed. These retired physicians aim to foster hope, resilience, and a more inclusive approach to dementia care.


Sponsored by Eisai, Genentech, Lilly, and Otsuka.

Older adults often do not obtain adequate amounts of micronutrients from their regular dietary patterns and are at risk for nutritional deficiencies. The risk of inadequate vitamin and mineral intake increases as people age. Supplementation with multivitamins and minerals may help older adults meet their nutritional needs. Experts discuss strategies for enhancing nutritional research and incorporating nutritional information into clinical practice guidelines to increase the clinicians’ confidence around multivitamins and mineral recommendations.


Sponsored by Haleon.

Alzheimer’s is one of the nation’s most pressing public health challenges, affecting nearly seven million Americans—a number expected to nearly double by 2050. Over the past two decades, coordinated federal, state, local, territorial, and tribal efforts have transformed the public health response to dementia, emphasizing risk reduction, early detection, safety, quality care, and caregiving.   The Healthy Brain Initiative (HBI), established in 2005, provides the framework for mobilizing the public health field to address brain health, dementia, and caregiving. Guided by the HBI Road Map Series, health departments implement expert-developed actions aligned to the Essential Public Health Services. Collectively, health departments and their partners have expanded data collection, strengthened the workforce, and advanced policy and practice across the country.   Building on this foundation, the Building Our Largest Dementia Infrastructure for Alzheimer’s Act (BOLD Act) of 2018—implemented by the Centers for Disease Control and Prevention—has distributed funding to state, local, territorial and tribal public health departments; created three BOLD Public Health Centers of Excellence to translate and disseminate the latest science and evidence on dementia risk reduction, early detection of dementia, and dementia caregiving; and increased the timely collection and analysis of data.   With the BOLD Reauthorization Act of 2024 and every state now maintaining its own Alzheimer’s plan, public health systems are better positioned than ever to reach diverse and priority populations. This Momentum session will explore the last two decades of public health action on dementia and look forward to the challenges still ahead to ensure all people, in all communities, can live with the healthiest brain possible.


Sponsored by Alzheimer's Association.

The GSA 2025 Program Website is Now Open 

To learn more about these sessions—including dates, times, and locations—and to begin building your personalized schedule, visit the GSA 2025 Program Website. Registered attendees can log in using their GSA ID to access full session details and abstracts.

View Momentum Discussions on the Program Website

Already registered for GSA 2025 but want to register for a Momentum Discussion?

  • Log into your GSA 2025 Account.
  • Click on "My Dashboard" in the top right corner.
  • Under “My Upcoming Events”, select "GSA 2025 Annual Scientific Meeting" and click "View Registration".
  • Select additional items to add to your registration (e.g., workshops, continuing education, or social events like pickleball), and follow the prompts to proceed to checkout.
  • Finalize your registration by selecting the "Update Registration" button.
Join Donate

Calendar of Events

Privacy Policy

Notices and Disclaimers

Code of Conduct

Gerontological Society of America
1101 14th Street NW, Suite 1220
Washington, DC 20005
United States
Phone: (202) 842-1275
Email: membership@geron.org

© Gerontological Society of America 2024 and all prior years. All rights reserved.

  • Contact info
  • Twitter
  • YouTube
  • Linkedin
  • Facebook
  • membership@geron.org
  • Back to top